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ACQUIRED NON-FAMILIAL OSTEOMALACIA OF 
VITAMIN-D-RESISTANT TYPE 
Bov FRAME. M.D.,* RICHMOND W. SMITH, JR., M.D.** 
AND GEORGE M. WILSON. JR.. M.D.*** 
Detroit, Michigan 
Hypophosphatemia associaled with vitamin D-resistant rickets has commanded 
increasing interest, yet despite the prominent clinical and metabolic features, 
the basic abnormality has nol been defined. Winters and associates' have written 
extensively on the familial aspects, and they also reviewed evidence for and against 
defective renal tubular function, secondary hyperparathyroidism and vitamin D re-
fractoriness as possible causal factors. 
As might be expected for patients with familial disease, both skeletal abnormalities 
and hypophosphatemia have been recognized shortly after birth.'^  The designation 
"congenital" has been applied to the refractory rickets in such cases. In most, but 
not in all of these children, a familial basis has been established. In contrast, scattered 
case reports exist in which the earliest clinical expressions of ostcomalicia appeared in 
adulthood, suggesting that latent familial and distinctly non-familial forms can occur. 
We are primarily concerned in this paper with the non-familial, non-congenital 
disorder, which hereafter is referred to as "acquired" refractory ostcomalicia. Although 
similarities exist between Ihis and Ihe congenital type, certain differences can be 
recognized, particularly in the light of recent experiences with trealment. We will 
draw from information accumulated in the literalure and from personal observations 
of two patients with presumably the acquired form, one of whom was previously 
reported in detail.^  Additional observations have confirmed our early impressions 
that high dietary phosphorus, achieved through the use of phosphate supplements, 
is of therapeutic value to at least certain patients with acquired, vilamin D-resistant 
osteomalacia. 
CASE REPORTS 
Case I. (H.F.H. #96 24 45) 
H. F., a 60 year old salesman, first experienced low back pain in January 
1959. Several weeks later, he noted ankle and foot pain which increased with 
weight bearing. General weakness and fatigue were prominent symptoms, and the 
back pain, aggravated by coughing and sneezing, gradually progressed in intensity 
to the point that motion, such as turning in bed, was almost unbearable. His 
general health otherwise was good, and historical evidence was lacking for dietary 
deficiency, diarrhea and renal calculi. When first examined in August 1959, he 
was considered to have a herniated lumbar disc, despite lack of neurological signs. 
In the initial laboratory studies, hemoglobin was 14 grams per 100 ml. and white 
cell count was 6500 with a normal cellular differential. Specific gravity of 1.019, 
acid pH and negative tests for protein and reducing substances were noted for 
the urine which on microscopic study was normal. Serological test for syphilis 
was negative. 
*Physician-in-Chargc. Fifth Medical Division 
** Physician-in-Charge. Division of Endocrinology 
Formerly, Associate Physician. Division of Arthritis 
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Figure la 
Pelvic x-ray film demonstrating bony demineralization and pseudo-fracture, right superior ramus. 
Figure lb 
Progress film after eight months oral phosphate feeding. Increase in mineral content of bone near 
site of pseudo-fracture is apparent. 
When later the symptoms progressed in severity and the original diagnosis 
seemed untenable, additional studies were performed. Fasting serum sugar was 100 mg., 
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Figure 2 
Photomicrographs of undecalcified iliac crest bone prepared by the method of Frost.* Wide osteoid 
seams are demonsiraieil belween lhe black bars. 
carotene 125 meg., crealinine 0.8 mg., calcium 10.3 mg., inorganic phosphorus* 
between 1.0 and 1.8 mg. and phospholipid phosphorus 10 mg. per 100 ml. Serum 
sodium was 137. potassium 3.8. chloride 96, and carbon dioxide 28.2 mcq. per liter. 
UrinarN calcium excretion was 87 mg. per 24 hours. Serum alkaline phosphatase 
•Hereafter referred to as serum phosphorus 
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was 10 and 12 Bodansky units, while acid phosphatase was 1.2 K. A. unils. Tubular 
reabsorption of phosphate (TRP) was 78 per cent (normal 86-95). Chromatographic 
pattern of urinary amino acids was normal.** Roentgenograms of the small intestine 
were normal. A linear zone of demineralization (pseudofracture) in the right superior 
pubic ramus was noted in the pelvic roentgenograms (Fig. 1-a). Widened and 
mcreased numbers of osleoid seams typical of osteomalacia were present in sections 
of bone (Fig. 2) obtained from an iliac crest open biopsy. 
The family history was negative for evidence of skeletal disease. Blood relatives 
vvere nol available to test for evidence of familial hypophosphatemia. 
SPECIAL STUDIES 
1. Renal Tubular Response to I. V. Parathyroid Extract and to I. V. Calcium. 
(a) Parathyroid extract, 200 units intravenously, produced less phosphaturic effect 
in the patient than in Ihe control subject, while basal phosphate excretion 
in the patient was three limes lhal in the control (Fig. 3). 
(b) Calcium gluconate, 15 mg. per kg. body weight, was given intravenously 
over a four hour period. Urinary phosphate excretion decreased approximately 
50 per cent while TRP increased to normal. Al this point intravenous para-
thyroid hormone was given (same dose and lot number as used above). 
Phosphate excretion rate increased as TRP returned to the original low value 
(Fig. 4). 
2. Phosphate Absorption Tests. 
One hundred ml. of the special phosphate solution* was given in single oral 
doses to the patient and control subject, both being in Ihe fasting state. For 
both palienis an increase was observed in serum phosphorus concentrations, 
comparable in rate and degree (Fig. 5). A similar result was c^ btaincd 
following the simultaneous ingestion of calcium lactate (Fig. 6). 
On the premise that the underlying defect was one of phosphorus depletion 
from hyperphosphaluria, trealment was begun with the special phosphate solution, 
30 ml. orally six times daily. Wiihin six weeks the patient reported complete relief 
of bone pain and tenderness as well as increased strength and sense of well-being. 
Treatment was continued, and eight months later laboratory siudies were repeated. 
Serum calcium was 9.0 mg. and phosphorus, still depressed, averaged 1.8 mg. 100 ml. 
Urinary excretion of calcium was now only 7 to 20 mg. per 24 hours. Serum alkaline 
phosphatase levels continued increased al 9.9 Bodansky unils. and tubular reabsorp-
tion of phosphate was even further reduced to 50 per cent. In pelvic x-ray films, 
a definite increase in mineral content was noted near the pseudofracture (Fig. l-b). 
The iliac crest was again biopsied and the previously mentioned histologic 
evidence of osteomalacia was still present. 
•196 gm. NajHPO^ and 47.4 gm. NaHjP04. H,0 in 4 liters aqueous solution 
**Kindly performed by Dr. C. E. Dent of London, England 
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Figure 3 
Effect of 200 units i.v. parathyroid extract (PTE) in patient H. F. and in control. Thc greatei 
phosphaturic effect in thc control ( > 3-fold) as compared to the patient H. F. ( < 1-fold) is evident 
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Figure 4 
Effects of i.v. calcium followed by parathyroid extract (PTE) in paticni H.E. During calcium 
infusion urinary phosphate excretion decreased concomitant with increased tubular reabsorption of 
phosphate (TRP). Parathyroid extract then increased urinary phosphate excretion and reduced its 
tubular reabsorption to the low base line level 
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( ase 2. (H.F.H. #60 83 72) 
A. E. , a 47 year old woman, was the subject of a previous report.' The clinical 
lislory. physical and biochemical findings, and skeletal roentgenographic and histologic 
observations were qualitatively similar bul more severe than those of the first case, 
nilial trealment in 1950 with vitamin D, IO(),(KK) to 180,000 unils, and 3.6 gm. 
alcium lactate daily had not resulted in any measurable improvement. The addition 
t oral phosphate supplements, totaling 2 gm. of phosphorus daily, was followed by 
Tompt relief of bone pain, healing of pseudofractures and improved metabolic 
alances for calcium and pht^ sphorus. This combined Ireatment was continued for 
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Figure 5 
i ponse of serum inorganic phosphorus to 
I' ll phosphate load. (See previous footnote). 
( mparable rise is noted in patient H. F. and 
II control. 
Figure 6 
Response of serum inorganic phosphorus to 
simultaneous oral calcium lactate and phosphate 
solution in patient H. F. Note that ingested 
calcium did not interfere with absorption of 
inorganic phosphorus. 
one year with sustained clinical improvement. Trealment with oral phosphate sup-
pl 'ment alone was then given for one year with continued healing of pseudofractures 
and freedom from pain. In July 1960, ten years after the initial observalions, serum 
calcium was 9.0 and phosphorus 1.5 mg. per 100 ml. Tubular reabsorption of 
phosphate remained low at 76 per cent, and serum alkaline phosphatase was still 
elevated at 12 Bodansky unils. Pseudofractures have remained healed, but a coarsened 
trabecular pattern, particularly in the lumbar vertebrae, suggests a continuing skeletal 
abnormality. 
CASE COMMENTS 
Evidence was lacking in both patients for the more common causes of osteomalacia 
such as dietary deficiencies, malabsorption and hypercalciuria. The late onset of 
>^mpioms and absence of skeletal abnormalilies in blood relatives suggested for 
both patients lhat the metabolic disorder was not familial. Serum concentrations of 
phosphorus were normal in the Iwo sons and sister of patient A. E. Similar deter-
minations were not possible in family members of patient H. F. Periinent bio-
chemical data were the normal levels of serum calcium, marked hypophosphatemia, 
increased levels of serum alkaline phosphatase and low urinary calcium excretion. 
Phosphate reabsorption by the kidney was impaired, while evidence was lacking for 
other lubular defects. Radiologic findings were those of osteomalacia, in keeping 
^iih the prominent and increased numbers of osteoid seams noted in bone seciions. 
In both patients the reduced TRP and increased basal phosphate excretion, 
h^en compared to the conlrol subject, suggested the possibility of excessive renal 
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Nornnal Condition 
Expernnental Osteomalacia 
(phosphorus starvation) 
TOOL STOOL 
SERUM P SERUM P 
Refractory Osteomalacia, Acquired Non-Familial 
(renal phosphate depletion) 
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Figure 7 
Schema of phosphorus movement. Width of arrows depicts magnitude of flow. 
phosphate loss. Parathyroid extract exhibited only minimal effect on phosphate 
excretion, suggesting that either the tubules were already under maximal hormonal 
influence or, irrespective of the level of tubular activity, the kidney was truly 
refractory to the hormone. That the tubular defect was not "fixed" or unresponsive 
was suggested by the reduced phosphate excretion and improved TRP which followed 
intravenous calcium. This new rate of reabsorption was then reversed by intra-
venously administered parathyroid hormone. However, a purely glomerular action 
by infused calcium and the subsequent hormone could not be excluded. 
The rapid rise in serum phosphorus observed in both patients following the 
ingestion of oral phosphate excluded the possibility that an absorptive block for this 
mineral was the primary defect. Calcium ingested simultaneously did not interfere 
with phosphate absorption, and no difference in the latter was noted between patient 
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A. E. , receiving large amounts of vitamin D, and patient H. F. who was untreated. 
A significant reduction in urinary calcium occurred in both patients during phosphate 
iherapy, and judged from the results of melabolic balance studies in patient A. E. , 
calcium retention was materially enhanced. That this was clinically signiticant was 
clearly evident in the remineralizalion of the pseudofractures noted in serial roentgeno-
grams for both patients. 
Lhe effecis of phosphate feeding could be clearly assessed in patient H. F., 
vho had nol received previous vitamin D or other therap\. His lavorable clinical 
jourse and improved skeletal status, judged by roentgenographic evidence, were 
imilar to those of patient A. E. The latter, clinically and metabolically refractory 
o vitamin D, had made a striking improvement after phosphate supplements were 
idded. As with patient H. F., however, presisieni fasting hypophosphatemia and 
icreased levels of serum alkaline phosphata.se were indicative of a continuing bio-
hemical defect. The question may be raised as to whether or not \itamin D 
contributed significantly or at all to her skeletal remission. Our opinion is that it 
id nol and that augmenting dietary phosphorus was Ihe decisive faclor. The 
, ivorable effect of the laller in alleviating bone pain and improving skeletal minerali-
zation in the two palients seems beyond question. 
In respect to patient H. F., it cannot be said that he was truly vitamin D-
rcsistanl since this agent in conventional doses was nol used in treatment. However, 
it is doubtful lhal the symptomatic response to vitamin D alone, even in large doses, 
uould have been more effective than that which was observed with phosphorus. To 
furlher reverse the histological evidence of osteomalacia, prolonged Ireatment with 
prosphorus will undoubtedly be required. These high levels of total phosphorus intake, 
approximating three grams daily, have been well loleraled without evidence of impaired 
renal function. The latier is mentioned only because renal damage in rats has 
resulted from high phosphorus intake.* 
The over-all evidence led lo a final diagnosis in bolh patients of acquired 
non-familial osteomalacia of vitamin D-resistani lype. The favorable response to 
Ireatment with oral phosphate was considered strong evidence lhat the basic disorder 
was phosphate depletion, presumably through hyperphosphaluria. 
DISCUSSION 
In Iheir review. Winters and co-workers' found 65 reported ca.ses of vilamin D-
resisiani rickets which they defined as a specific disorder, similar clinically, bio-
chemically and radiologically to vilamin D deficiency rickets bul resistant to this 
vitamin except in very large doses. In their judgment, the disease is almost always 
inherited and usually congenital. Considerably fewer reported patients appear to 
have had the acquired form of the disease. In the older literalure, cases reported 
by Debray,* Milkman' and Leedham-Green* may have been examples of acquired 
vilamin D-resistant osteomalacia, bul the evidence is inconclusive. Olher more re-
cently reported cases'" are apparent examples of Ihe acquired form. Bakw in's*' 
case may also have been of this type despite the early age of onset. Swann" and 
others'*" have reported the interesting though unexplained association of neuro-
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fibromatosis and acquired refractory osteomalacia. In their review of hereditary 
rickets and osteomalacia. Dent and Harris" record information on four young adults 
who apparently have an acquired but slightly different form, since increased glycinuria 
and mild acidosis were present. 
Features common to the congenital and acquired types of refractory osteo-
malacia are the persistent hypophosphatemia, increased renal clearance of phosphate, 
decreased intestinal absorption of calcium and failure to respond to conventional 
doses of vilamin D. On the other hand, there are clinical differences to be recognized. 
Muscular weakness, more characteristic of the acquired form, is often so pro-
found as to limit activity and, in some instances, muscle wasting and adynamia are 
presenL'*'* The weakness is suggestive of lhat associated with hypokalemia, but 
this and areflexia have not been reported. We have noted that increased strength, 
an early sign of improvement following the institution of oral phosphate supplements, 
has occurred withoul concomitant increase in fasting levels of serum phosphorus. 
Meroney" observed muscle weakness in a patient with hypophosphatemia to improve 
after supplementary phosphate feeding. That depleted body phosphorus might result 
in imparied muscle function is not surprising in view of the importance of high 
energy phosphate bonds to muscular contraction. Whether or not intracellular 
phosphorus is reduced during extracellular phosphorus depletion is not known. 
In contrast, thc hypophosphatemia in congenital refractory rickets is not usualh 
associated with significant muscle weakness. The authors have under observation 
three children with the latier condition, and all have normal strength and stamina 
That age is not a factor in Ihis difference is suggested by the occurrence of muscle 
weakness and adynamia in infants with vitamin D-deficicncy rickets and hypo-
phosphatemia. 
In patients with the acquired type of refractory osteomalacia, bone pain and 
tenderness oflen restrict physical activity. When prolonged, Ihis immobilization may 
result in superimposed osteoporosis such as we believe occurred in patient A. E. 
of the present report. In contrast, patients with congenital refractory rickets are 
usually free of skeletal pain and tenderness. This we have observed in three patients, 
despite persistent hypophosphatemia and radiologic evidence of marked skeletal de-
formities. 
Differences in the clinical course of the two types might suggest basically 
different diseases. However, since the contrast is between a childhood and adult 
illness, the phenomena of growth and sexual maturation must be considered as 
possible conditioning factors. The congenital form tends to abate clinically and 
radiologically during adolescence. Serum concentrations of alkaline phosphatase often 
decrease to normal, although hypophosphatemia may persist." On the other hand, 
the untreated acquired form of refractory osteomalacia is generally progressive, 
although Dent" has observed an apparent remission in the case originally reported 
by McCance.' 
Winters and co-authors'" have cited the considerable clinical evidence that 
vitamin D in large amounts facilitates healing of congenital refractory rickets. How-
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•ver, such therapy is not always effective and hypercalcemia may result. For Ihese 
easons, other therapeutic measures such as increasing dietary phosphorus have been 
ried. Evidence suggests that this approach, achieved by the use of oral phosphate 
upplements, is more effective in refractory osteomalacia of the acquired type. For 
patients with the later disease, results similar to those we are reporting have been 
bserved by Henneman'* and Jarowski". Meroney" reported a positive calcium 
dance of 500 mg. per day in a patient with acquired refractory osteomalacia 
ceiving a normal diet supplemented with four grams of phosphorus. 
In contrast, neither radiologic evidence of bone healing nor improved mineral 
alances were noted in three children with congenital refractory rickets who received 
nly phosphate supplements for a period of one year." Likewise, Frazer in a personal 
^mmunication to Winters" expressed a lack of confidence in such therapy for the 
>ngenital disorder. This apparent difference in response to phosphorus may be 
nother distinguishing feature between the congenital and acquired forms. However, 
plausible explanation for this refractoriness in children should not be overlooked. 
' he normal phosphorus concentration in serum is substantially higher in children 
an in adults, and adequate mineralization in the former might occur only at the 
:her level. If true, even sizable amounts of dietary phosphorus may prove in-
equate to "push" serum phosphorus concentrations in children to the higher level 
I cessary for skeletal mineralization. Furthermore, the bone of children may have 
a greater competition with other somatic struclures, such as muscle and liver, for 
available phosphorus. 
In Figure 7 is schematically outlined the metabolic derangement for phosphorus 
in refractory osteomalacia of the acquired, non-familial type as it has been considered 
il the present report. For comparison, a similar schema is included for experimental 
oMeomalacia in phosphorus-deprived rats," which is also resistant to the action of 
vilamin D.^ The central thesis for both is that phosphorus depletion alone, in the 
f^ r^mer from an apparent renal phosphate leak and in the latter from inadequate 
dietary supply, can result in osteomalacia. Suppressed calcium absorplion is con-
siiiered to be sequential to a hypophosphatemic block in skeletal mineralization. The 
parathyroids, if they have any role, would then serve to correct the hypocalcemic 
tendency which may occur early in the course of the disease. When phosphate is 
given in amounts adequate transiently to increase serum phosphorus levels in patients 
V^Ith acquired refractory osteomalacia, remineralizalion can temporarily proceed. The 
resulting utilization of serum calcium for mineralization then necessitates a secondary 
increase in calcium absorption. The above explanation is compatible with Harrison's^ ' 
thesis that intestinal absorption of calcium proceeds at a rate which is dependent to 
a large degree upon the rate of skeletal mineralization. If correct, this explanation 
would relegate vitamin D to a role of questionable significance in both the patho-
genesis and treatment of acquired refractory osteomalacia. 
SUMMARY 
The metabolic defect of refractory osteomalacia has been discussed in the light 
of recent knowledge concerning its natural history and treatment. Although bio-
chemically similar, the congenital and acquired forms appear to have differences 
in the clinical course and response to treatment. The case histories have been 
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presented of two patienls with the acquired form in whom favorable treatment with 
high dietary phosphorus stand in conirast to the poor results observed in palients with 
Ihe congenital disease. Since phosphorus repletion alone may be beneficial, Ihe thesis 
that vilamin D refractoriness is Ihe primary defect may not be applicable to all 
patienls with this interesting disorder. 
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